)
IDEXX Laboratories (IDXX) investor relations material
IDEXX Laboratories 47th Annual Raymond James Institutional Investor Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic overview and market opportunity
Pursuing an innovation-driven strategy targeting a $45B+ global veterinary testing market, emphasizing diagnostics as foundational to practice health.
Developing extensible platforms for point of care, software, and reference labs, leveraging installed base through menu extensions, vertical SaaS, and AI enablement.
Commercial ecosystem expansion and customer partnerships drive awareness, education, and testing adoption, with international growth outpacing the U.S.
Significant runway to expand premium instrument installed base over 3x globally, supported by investments in infrastructure and commercial teams.
Long-term organic revenue growth potential projected at 10%+ with high return on invested capital.
Financial performance and growth drivers
Achieved double-digit growth in both U.S. and international markets, with international recurring revenue growing from $0.7B in 2020 to $1.2B in 2025 at a 12% CAGR.
Diagnostics revenue growth outpaces total practice and clinical revenue, driven by differentiated and integrated solutions.
Pet longevity has increased by 22% since 2010, and increased pet adoption during the pandemic creates long-term tailwinds for diagnostics demand.
Diagnostic spend rises with pet age; top third of practices use 1.5x more diagnostics than average.
Long-term financial model targets 10%+ revenue growth, 50–100 bps operating margin expansion, and 15%+ EPS growth.
Innovation and product development
Accelerated investment in innovation, with $1.2B planned over four years starting 2025 and cumulative R&D investment exceeding $2.4B.
Focused on premium instruments, biomarkers, software, data, and AI enablement to address multi-billion-dollar disease states.
Expanded vector-borne disease and parasitology testing menus, improving early detection and coverage.
Renal and oncology diagnostics enhanced with early detection markers and expanded test panels.
Point-of-care analyzers like Catalyst and inVue Dx offer menu extensibility and workflow integration, advancing cytology testing.
Next IDEXX Laboratories earnings date
Next IDEXX Laboratories earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage